Menu
Tri-Institutional MD-PhD Program
Found 6 results
Filters: Keyword is Adenocarcinoma  [Clear All Filters]
2017
Xue Y, Martelotto L, Baslan T, Vides A, Solomon M, Mai TThi, Chaudhary N, Riely GJ, Li BT, Scott K et al..  2017.  An approach to suppress the evolution of resistance in BRAF-mutant cancer.. Nat Med. 23(8):929-937.
de Geus SWL, Eskander MF, Kasumova GG, Ng SChau, Kent TS, Mancias JD, Callery MP, Mahadevan A, Tseng JF.  2017.  Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review.. Cancer. 123(21):4158-4167.
Perez K, Clancy TE, Mancias JD, Rosenthal MH, Wolpin BM.  2017.  When, What, and Why of Perioperative Treatment of Potentially Curable Pancreatic Adenocarcinoma.. J Clin Oncol. 35(5):485-489.
2016
David CJ, Huang Y-H, Chen M, Su J, Zou Y, Bardeesy N, Iacobuzio-Donahue CA, Massagué J.  2016.  TGF-β Tumor Suppression through a Lethal EMT.. Cell. 164(5):1015-30.
2013
Snyder EL, Watanabe H, Magendantz M, Hoersch S, Chen TA, Wang DG, Crowley D, Whittaker CA, Meyerson M, Kimura S et al..  2013.  Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma.. Mol Cell. 50(2):185-99.
1988
Pomerantz AH, Derasari MD, Sethi SS, Khan S.  1988.  Early post-pneumonectomy bronchial stump fistula.. Chest. 93(3):654-7.